Franck's Lab Inc., d.b.a. Franck's Compounding Lab Recall: ATROPINE SULFATE 0.4MG/ML INJEC
Franck's Lab Inc., d.b.a. Franck's Compounding Lab Recall: ATROPINE SULFATE 0.4MG/ML INJEC is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Franck's Lab Inc., d.b.a. Franck's Compounding Lab; Product: ATROPINE SULFATE 0.4MG/ML INJECTABLE 12 ML, 2 ML, 20 ML, 24 ML, 25 ML, 3 ML; ATROPINE/
| Recalling firm | Franck's Lab Inc., d.b.a. Franck's Compounding Lab |
|---|---|
| Product | ATROPINE SULFATE 0.4MG/ML INJECTABLE 12 ML, 2 ML, 20 ML, 24 ML, 25 ML, 3 ML; ATROPINE/EPINEPHRINE/ BSS 0.02MG/0.1MG/ML INJECTABLE 10 ML, 5 ML (8 DIFFERENT PRODUCTS) |
| Reason for recall | Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies |
| Recall initiated | 20120525 |
| Recall number | D-1458-2012 |
| Category | drug |
| State | FL |
| Country | United States |
$29/mo
Try RecallGuard →